Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine + HAAG in ETP-ALL/LBL and MPAL
NCT04446130Phase 3Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jan 2019
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL), mixed phenotype acute leukemia (MPAL), t-cell acute lymphoblastic leukemia (T-ALL), T cell lymphoblastic lymphoma (T-LBL), sponsored by First Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
decitabine
03
Conditions
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL)mixed phenotype acute leukemia (MPAL)t-cell acute lymphoblastic leukemia (T-ALL)T cell lymphoblastic lymphoma (T-LBL)
Beyond the preview
Go deeper on NCT04446130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04446130.